Nav: Home

Northwestern Memorial Hospital recognized by CDC for innovative efforts to prevent blood clots

March 31, 2016

Northwestern Memorial Hospital was one of eight hospitals and health systems recognized by the U.S. Centers for Disease Control and Prevention (CDC) as Healthcare-Associated Venous Thromboembolism (HA-VTE) Prevention Champions. Venous thromboemboli, or VTE, are blood clots that form deep in the body, in the lungs, or both. Northwestern Memorial was recognized for its success in implementing innovative and effective ways to prevent VTE in healthcare settings.

VTE is a serious and growing public health problem with an estimated 900,000 VTE events occurring in the U.S. each year, resulting in as many as 100,000 premature deaths. VTE-associated healthcare costs may be as high as $10 billion a year. People who are currently or recently hospitalized, recovering from surgery, or being treated for cancer are at increased risk for developing these deadly blood clots.

"Approximately half of all VTE occur in patients who are hospitalized or recovering from surgery," said Karl Y. Bilimoria, MD, MS, vice chair for quality in the department of Surgery for Northwestern Medicine and director of the Northwestern Surgical Outcomes and Quality Improvement Center. "To ensure that we were providing the best possible care for our patients, we implemented a comprehensive, multi-year initiative to prevent blood clots after surgery. We are proud to be recognized for this team effort that involved physicians, nurses, patients, process improvement engineers, quality improvement experts and our executive leadership."

Northwestern Memorial's VTE prevention success relied upon several factors, including:
  • Support from senior clinical leadership and hospital administration
  • Educational intervention among physicians and nurses to develop their skills and engage their support
  • Improvements in the electronic medical record system to advance safe and consistent practice
  • Robust collaboration among surgical and medical clinicians to define and adopt VTE prevention practices
  • Continuous monitoring of unit-specific performance by hospital leadership, clinical process owners and frontline nurse managers
  • Dedicated focus on systematic measurement and feedback, using data to drive improvement.

For more information on Northwestern Memorial's HA-VTE prevention strategies, visit http://www.cdc.gov/ncbddd/dvt/documents/champ-fact-sheet-northwestern-il.pdf. The HA-VTE Champions are a group of eight institutions ranging from a small community hospital to some of the country's largest health systems, representing both rural and urban areas. Together, the organizations cared for more than 450,000 patients admitted to hospitals across the United States in 2014. To learn how these facilities were able to improve VTE prevention by implementing innovative, effective and sustainable strategies, visit the CDC: http://www.cdc.gov/ncbddd/dvt/ha-vte-challenge.html.

"These challenge winners saved lives by implementing innovative VTE prevention strategies in their institutions," said CDC Director Thomas Frieden, MD, MPH. "We can all learn from their ideas and work together to protect patients from developing deadly blood clots."

The HA-VTE Prevention Challenge was launched on November 2, 2015, to find and reward hospitals, managed care organizations and hospital networks that implemented innovative and effective ways to prevent HA-VTE. CDC, along with the Agency for Healthcare Research and Quality (AHRQ), is sharing these best practices with others to help strengthen VTE prevention efforts.
-end-
About Northwestern Medicine®

To learn more about Northwestern Medicine, please visit: http://news.nm.org/about-northwestern-medicine.html.

Northwestern Memorial HealthCare

Related Blood Clots Articles:

New ultrasound 'drill' targets deep vein blood clots
Researchers have developed a new surgical tool that uses low-frequency intravascular ultrasound to break down blood clots that cause deep vein thrombosis.
New blood thinner better at preventing recurrent blood clots than aspirin
An international research team with prominent Canadian leadership has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of life-threatening blood clots in the legs and lungs, according to a study being published in the New England Journal of Medicine and presented at the American College of Cardiology's 66th Annual Scientific Session.
Preventing blood clots with a new metric for heart function
Scientists from Johns Hopkins University and Ohio State University have discovered a new method for predicting those most at risk for thrombus, or blood clots, in the heart.
Statins could halt vein blood clots, research suggests
Statins could hold the key to eradicating one of the most preventable causes of hospital deaths after researchers uncovered a new role for the cholesterol-lowering pill.
Exploring why an anticoagulant might create blood clots
An oral anticoagulant drug given to some heart disease patients may actually enhance blood clot formation, according to a new study.
Increased risk of blood clots soon after starting testosterone treatment
Starting testosterone treatment is associated with an increased risk of serious blood clots (known as venous thromboembolism or VTE) that peaks within six months and declines gradually thereafter, concludes a study in The BMJ today.
New technology detects blood clots with simple in-home test
NSF-Funded UC research leads to a screening test for patients on blood thinners to reduce the risk for a blood clot or stroke that's as easy as an in-home diabetes test.
Link found between obesity and blood clots in pediatric patients
Researchers at Wake Forest Baptist Medical Center have found an association between obesity and the formation of blood clots in the veins of children and adolescents.
Detecting when and why deadly blood clots form
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.
Blood clots may complicate aortic valve replacements
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation.

Related Blood Clots Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".